Signaling Pathways
Signaling Pathways(信号通路)
- Proteases(63)
- Apoptosis(1190)
- Chromatin/Epigenetics(17)
- Metabolism(420)
- MAPK Signaling(32)
- Tyrosine Kinase(97)
- DNA Damage/DNA Repair(62)
- PI3K/Akt/mTOR Signaling(56)
- Microbiology & Virology(68)
- Cell Cycle/Checkpoint(205)
- Ubiquitination/ Proteasome(43)
- JAK/STAT Signaling(13)
- TGF-β / Smad Signaling(30)
- Angiogenesis(85)
- GPCR/G protein(3)
- Stem Cell(27)
- Membrane Transporter/Ion Channel(273)
- Cancer Biology(514)
- Endocrinology and Hormones(168)
- Neuroscience(462)
- Obesity, Appetite Control & Diabetes(9)
- Peptide Inhibitors and Substrate(1)
- Other Signal Transduction(141)
- Immunology/Inflammation(1111)
- Cardiovascular(63)
- Vitamin D Related
- Antibody-drug Conjugate/ADC Related
- PROTAC(254)
- Ox Stress Reagents(25)
- Others(1718)
- Antiparasitics(21)
- Toxins(90)
Signaling Pathways 相关产品(35130)
- GC13518CinacalcetCAS: 226256-56-0纯度: >99.50%
Cinacalcet (AMG 073) 是一种具有口服活性的 Ca 受体 (CaR) 变构激动剂,用于心血管疾病的治疗。
- GC13535FluvastatinCAS: 93957-54-1纯度: >98.00%
Fluvastatin是一种亲脂性的3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂,可在多种癌细胞中抑制增殖并诱导凋亡。
- GC13547Dovitinib (TKI-258, CHIR-258)CAS: 405169-16-6纯度: >98.00%
Dovitinib (TKI-258, CHIR-258)是一种高效,具有口服活性和安全药代动力学特性的小分子多激酶抑制剂,作用于FLT3、KIT和FGFR等靶点,IC 50 值分别为1、2和8-9nM。
- GC13559CilengitideCAS: 188968-51-6纯度: >99.00%
Cilengitide是一种环化五肽,是一种强效整合素拮抗剂,对ανβ3、ανβ5和α5β1的IC 50 值分别为0.61nM、8.4nM和14.9nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC13514 | NG25 | 1315355-93-1 | >98.00% | |
NG25是一种强效且可渗透细胞的TGF-β-活化蛋白激酶1(TAK1)和丝裂原激活蛋白激酶激酶激酶激酶2(MAP4K2)抑制剂,IC 50 值分别为149nM和21.7nM。 | ||||
| GC13517 | BAPTA-AM | 126150-97-8 | >99.00% | |
BAPTA-AM 是一种众所周知的可透过膜的 Ca2+ 螯合剂,可通过减轻细胞内钙过载来防止细胞损伤。 | ||||
| GC13518 | Cinacalcet | 226256-56-0 | >99.50% | |
Cinacalcet (AMG 073) 是一种具有口服活性的 Ca 受体 (CaR) 变构激动剂,用于心血管疾病的治疗。 | ||||
| GC13522 | Merimepodib | 198821-22-6 | >98.50% | |
An IMPDH inhibitor | ||||
| GC13523 | Amlodipine | 88150-42-9 | >99.50% | |
An L-type calcium channel blocker | ||||
| GC13527 | Gliclazide | 21187-98-4 | >99.50% | |
An inhibitor of pancreatic β-cell K ATP channels | ||||
| GC13533 | Cisapride | 81098-60-4 | >99.50% | |
A 5-HT 4 receptor agonist | ||||
| GC13535 | Fluvastatin | 93957-54-1 | >98.00% | |
Fluvastatin是一种亲脂性的3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂,可在多种癌细胞中抑制增殖并诱导凋亡。 | ||||
| GC13539 | SB-334867 | 249889-64-3 | >98.00% | |
An orexin 1 receptor antagonist | ||||
| GC13543 | Poloxin | 321688-88-4 | >98.50% | |
An inhibitor of the Plk1 polo-box domain | ||||
| GC13544 | Voreloxin | 175414-77-4 | - | |
An inhibitor of topoisomerase II | ||||
| GC13547 | Dovitinib (TKI-258, CHIR-258) | 405169-16-6 | >98.00% | |
Dovitinib (TKI-258, CHIR-258)是一种高效,具有口服活性和安全药代动力学特性的小分子多激酶抑制剂,作用于FLT3、KIT和FGFR等靶点,IC 50 值分别为1、2和8-9nM。 | ||||
| GC13558 | PIM-1 Inhibitor 2 | 477845-12-8 | - | |
A potent PIM-1 kinase inhibitor | ||||
| GC13559 | Cilengitide | 188968-51-6 | >99.00% | |
Cilengitide是一种环化五肽,是一种强效整合素拮抗剂,对ανβ3、ανβ5和α5β1的IC 50 值分别为0.61nM、8.4nM和14.9nM。 | ||||
| GC13561 | PA-824 | 187235-37-6 | >99.50% | |
PA-824是一种硝基咪唑类抗结核药物,PA-824可通过抑制结核分枝杆菌细胞壁合成和干扰能量代谢来杀灭细菌。 | ||||
| GC13566 | NVP 231 | 362003-83-6 | >98.50% | |
A potent and reversible inhibitor of ceramide kinase | ||||
| GC13569 | Flunixin Meglumin | 42461-84-7 | >99.50% | |
A COX inhibitor | ||||
| GC13572 | Lornoxicam | 70374-39-9 | >99.50% | |
A COX inhibitor and NSAID | ||||
| GC13576 | TC-G 24 | 1257256-44-2 | - | |
TC-G 24 (Compound 24) 是一种有效的、选择性的糖原合酶激酶-3β (GSK-3β) 抑制剂,IC50 为 17.1 nM。 | ||||
| GC13589 | CID 755673 | 521937-07-5 | >99.50% | |
An inhibitor of protein kinase D | ||||
| GC13591 | TC-H 106 | 937039-45-7 | >98.00% | |
A tight-binding inhibitor of class I HDACs | ||||
| GC13592 | PD173955 | 260415-63-2 | >99.00% | |
A tyrosine kinase inhibitor | ||||
| GC13593 | Albendazole | 54965-21-8 | >98.00% | |
A benzimidazole anthelmintic | ||||
| GC13596 | SRPIN340 | 218156-96-8 | >99.50% | |
A selective inhibitor of SRPK1 | ||||
